NCT06258577View on ClinicalTrials.gov

Screening for Gaucher Disease and Acid Sphingomyelinase Deficiency

Not yet recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions
Gaucher Disease
Trial Locations (1)

Unknown

China Medical University Hospita, Taichung

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Chung-Hsing Wang

OTHER

NCT06258577 - Screening for Gaucher Disease and Acid Sphingomyelinase Deficiency | Biotech Hunter | Biotech Hunter